Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'll sell when the market cap is more than what I deem to be the enterprise valuation. The problem is that right now the enterprise valuation isn't accurately quantifiable, with so many of the company's technologies and lines of business in their developmental stages. When the enterprise valuation is clearer, that's when I'll make a decision, but until then I'm holding until it becomes evident, because by selling there is a tremendous risk of leaving value on the table until that happens.
I love this company, but if the share price were to get to $100 that would give it a market cap of roughly $10 billion. To put things in perspective, the company for which I work has a market cap of roughly $1.8 billion with sales of $635 million and earnings of just under $5.00 per share. iQSTEL is a great company, but it has a long way to go before it will command a market cap of $10 billion. It is nice to dream, though!
If it does, my debt of gratitude to you would be a little over $437K!
That is absolutely amazing, and reflective of iQSTEL's superb performance through the first half of Q1 2021.
To Knux, Peter, Moneyman, Gigantor, Tyrus and all the others who watch and understand the technical action - thank you for your insights. I know nothing of charts, MM behavior, and those kinds of things, so to have you interpret the iQSTEL world as it happens around us is invaluable as we watch the story play out now and in the future. All I know is my take from both a fundamental and enterprise valuation perspective on what I believe we have here, and I know it's much higher than what the share price is telling us it is right now.
I'd say that's good value for the roughly 2,230,000 shares. We get the benefit of becoming debt-free and paying less interest, they get shares that are now worth more than twice the price for which they exchanged them - everyone is happy!
That would definitely help our causes! I'm glad they're taking action!
Post 22642 details the key to this company's valuation. That is where the true long-term value of this company is, not in any of their other product lines. If you disagree with that assertion, then that is the enjoyable part about the stock market - the disagreement between buyer and seller in every trade that takes place.
The whole thing is pretty simple, really. If the company continues to expand its scope of business and grows its revenue and earnings at the pace at which it has recently, the share price will go up under the well-controlled capital structure that it has created no matter what shorts or longs think or say.
That is very good to know - thanks for doing the legwork! He seems to be a reputable analyst, and his input is extremely useful.
I personally like the most recent Goldman report, which is the second item you'll see at the top of the page if you click the iQSTEL link. I think it gives a very good summary of the company and its operations.
I'm just going to do what I always do, which is to keep the money in a stock as long as I think that there is nowhere else better to deploy the money that has better long-term appreciation potential. Right now, despite two other tremendous companies in which I hold shares and am extremely confident, this money is staying here, and I have trouble envisioning it moving elsewhere for quite some time.
I'm finding, not only here but with other companies, that the key to being successful in investing is to be able to figure out when the intrinsic value of a company is much higher than its current market cap and then just to buy its shares and wait! It sounds easy, but it requires good analysis and judgement, and oftentimes patience until others also figure it out.
I'll wait to see what happens in June - when construction starts I also think the share price will rise.
Being eternally in your debt for the other one that is going to make me rich, I'm looking at this one too. I'm interested in how you think this might go to $15-30 this year, because it seems like it needs to at least start the Louisiana construction project to move beyond this level, and wouldn't that take a while to come on line?
They're bullish here because Aileron's drug has the potential to be bigger than GTHX's is going to be, and they just got FDA approval to start the whole chemoprotection industry off and give it validation. If they can get this through the trials and get approval, this is a $100 stock. I'll be buying all I can over the next couple of years. This will not be at $2.00 for very long.
Brilliant analysis. You have verbalized what my intuition told me was of massive importance and value in a way that I could not have. It's obvious that the share price does not reflect the value that this product represents, and in fact, it may not be possible to accurately value it at this time.
I think it will, Big RDC. It excites me to think about the possibility of the IoT device for which we signed an LOI with the Fortune 500 company performing its function successfully and becoming an industry standard, as if it meets their requirements, probably many others in the industry will want to have the same thing in order to stay competitive. The good thing is that that is only one facet of our operations!
You're welcome, Oldman. I played the pink sheet stocks a couple of decades ago, and made more money than I ever dreamed possible and then lost virtually every last dollar of it when they collapsed, so I've seen probably dozens of the kind of stock on which you were asking an opinion. I swore I'd never play any of them again, but when I was tipped to this one and looked at it closely, it became clear to me that this one was very different from any pink sheet company I had ever seen, in that it was an actual company with high-quality audited financial statements and legitimate operations.
From one oldman to another, I think that's a good idea.
In a word, no - not with over 12 billion shares outstanding and zero revenues in the most recent quarter.
Now I'm holding more than a double! When is someone going to join me here on the money train for the long profitable ride?
In response to the nice recent movement, I picked up some earlier this week. If they get their Parkinson's drug going, this is a $20.00 stock. Even without it, it's eventually at least a $5.00 stock. When it moves up, it moves fast.
I'm betting that they will be able to market the drug for this indication better than they did for the previous one, so I just picked up more today, and will continue to do so through the PDUFA date of April 29. I think the demand is there this time.
It's funny with biopharmas - I've seen them run up to an event and then drop after the news, but I think this is different. With this one I honestly think that this is the beginning of the development of an extremely profitable company that might end up with it being acquired by a bigger fish, so I'm not going to play any games with it like selling into momentum and then buying on the dip - I'm just holding. I'd be happy with $40 by the end of the day on Tuesday, but I really believe it will be $80 a year from now. In the back of my mind I think Jack Bailey might want to take this company back home to SmithKlineGlaxo after a while.
YESSSSS!! I made a big bet on this one thinking Jack Bailey wouldn't easily make the decision to give up his career at SmithGlaxoKline to come here unless it was very promising, and I was right! I can hardly wait until Tuesday morning's open!
I had to say goodbye to Abeona earlier this week when its price rose above my basis, as I swore to myself that I would do so if it ever recovered from its rapid decline to $1.00. I split it among three other biopharmas which I think have more immediate prospects of bringing their pipelines to revenue-generating fruition. This is a good company, but I think bringing their pipeline to revenue-generating fruition will take awhile from this point. Michael Amoroso should get a lot of credit for what he's done so far as Abeona's leader. Good luck to all who invest here. You could find a lot worse companies in which to invest.
Thanks for the link. The guess, and it's only a guess, is that next week they will announce that they will be filing it and/or have filed it at the time of the announcement.
That's also a possibility. I'll need someone with more knowledge about these issues than I have to comment on this.
I just saw what you saw on the Ambassadors' site, which was a reply by iQSTEL that included the phrase "when Form 10 is approved and we move up" in response to an Ambassador's comment. According to Moneyman's information, the Form 10 could be approved in sixty days, but I still can't see how we could move up without meeting the $2.00 qualification. Maybe Form 10 can be approved and held in abeyance until the $2.00 qualification is achieved?
It's possible, although with the 10-K filing due in mid-March, it wouldn't surprise me to have them hold off on disclosing any preliminary 2021 results until the 2020 statements have been filed.
We'll be looking forward to it!
I agree - it's just hard to imagine that the market's judgement can be so disparate and incorrect in the case of the juxtaposition between them and us. Their press releases are much more pink sheetlike than ours when they talk about zeitgeist and becoming a billion dollar company - maybe the market eats that up for some reason.
Can ANYONE here tell me why ALPP, with nine-month revenues of $26.6M and an operating loss of $3.3M with 138M shares outstanding trades at $8.10 for a market cap of over $1.1 billion, while IQST, with nine-month revenues of $29.4M and an operating loss of $2.5M with 96M shares outstanding trades at $.76 for a market cap of $72 million? Maybe we should start talking about zeitgeist and becoming a billion dollar company the way they do in their press releases - it seems to work!
That's one of the best posts I've seen here, and it reflects exactly my feelings about our situation.
It's certainly not the market reaction I expected from an announcement like that. The fact that a Fortune 500 company even knows who a company of this size is, let alone signs a letter of intent to do business with them, should be worth much more than a $.14 rise in the share price. I think we may own a company that acts much less like a pink sheet company than most, which is to say that our share price will largely react to solid development in revenue and earnings, contrary to most pink sheet companies, whose share prices largely react to hype and unrealistic and/or unsupportable press releases.
I could definitely see that being accurate.
That ought to drive us over a buck today! Maybe even at the open!
I can't see how they could do that without the share price reaching $2.00 first for a period of time.
It sounds as though you, as many others here do, understand the game that apparently is being played much better than I do - I don't use charts, trends or any of those things, so I appreciate your insight. I just buy undervalued companies and wait for them to further develop their business, which with a competent management team such as we have here leads to increasing revenues and earnings, and inevitably an increasing share price follows.